Nivolumab demonstrates benefit over nomogram-predicted 12-month survival as salvage therapy for metastatic urothelial carcinoma Meeting Abstract
| Authors: | Pond, G. R.; Sonpavde, G.; Galsky, M. D.; Sharma, P.; Rosenberg, J. E.; Choueiri, T. K.; Bellmunt, J.; Lee, J. L.; Lee, S. I.; Azrilevich, A.; Yang, S.; Gooden, K. M.; Bajorin, D. F. |
| Abstract Title: | Nivolumab demonstrates benefit over nomogram-predicted 12-month survival as salvage therapy for metastatic urothelial carcinoma |
| Meeting Title: | 2018 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2018 Feb 8-10 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-20 |
| Language: | English |
| ACCESSION: | WOS:000436179500445 |
| DOI: | 10.1200/JCO.2018.36.6_suppl.451 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 451 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
